LncRNA DDX11-AS1 regulates SNAI1/ZEB2 expression and activates the Wnt/β-catenin pathway via sponging miR-30d-5p as an epithelial-mesenchymal transition (EMT)-related lncRNA to advance ESCC progression, indicating it might serve as a therapeutic target for ESCC [11]. The gene discussed is DDX11; the disease is esophageal squamous cell carcinoma.